MedTrace Logo

Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma

NCT02060435 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 571

Last updated 2014-02-12

No results posted yet for this study

Summary

The investigators analyzed clinical outcome in DLBCL patients according to age group to define the impact of EBV status on the clinical outcome.

Conditions

  • Diffuse Large B-cell Lymphoma

Interventions

OTHER

EBER

EBV RNA was detected by an in situ hybridization (ISH) technique using the EBV ISH kit (Leica Microsystems, Bannockburn, IL, USA).

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Won Seog Kim, MD PhD · Samsung Medical Center

Eligibility

Min Age
17 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-12-31
Completion
2014-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02060435 on ClinicalTrials.gov